These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 34048739)
21. Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP Qi H; Shen D; Jiang C; Wang H; Chang M Neurosci Lett; 2021 Jan; 741():135493. PubMed ID: 33181233 [TBL] [Abstract][Full Text] [Related]
22. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis. Ren ZL; Wang CD; Wang T; Ding H; Zhou M; Yang N; Liu YY; Chan P Acta Pharmacol Sin; 2019 Apr; 40(4):441-450. PubMed ID: 29991712 [TBL] [Abstract][Full Text] [Related]
23. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Perfeito R; Cunha-Oliveira T; Rego AC Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292 [TBL] [Abstract][Full Text] [Related]
24. P7C3 inhibits GSK3β activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo. Gu C; Zhang Y; Hu Q; Wu J; Ren H; Liu CF; Wang G Cell Death Dis; 2017 Jun; 8(6):e2858. PubMed ID: 28569794 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP Rani L; Ghosh B; Ahmad MH; Mondal AC Mol Neurobiol; 2023 Aug; 60(8):4693-4715. PubMed ID: 37145378 [TBL] [Abstract][Full Text] [Related]
26. Vanillin Mitigates the MPTP-Induced α-Synucleinopathy in a Mouse Model of Parkinson's Disease: Insights into the Involvement of Wnt/β-Catenin Signaling. Rani L; Mondal AC J Integr Neurosci; 2024 Sep; 23(9):175. PubMed ID: 39344237 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity. Wang W; Yang Y; Ying C; Li W; Ruan H; Zhu X; You Y; Han Y; Chen R; Wang Y; Li M Neuropharmacology; 2007 Jun; 52(8):1678-84. PubMed ID: 17517424 [TBL] [Abstract][Full Text] [Related]
28. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis. Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D Front Immunol; 2018; 9():2527. PubMed ID: 30455692 [TBL] [Abstract][Full Text] [Related]
29. Valproic Acid Protects Primary Dopamine Neurons from MPP Zhang C; Yuan X; Hu Z; Liu S; Li H; Wu M; Yuan J; Zhao Z; Su J; Wang X; Liao Y; Liu Q Biomed Res Int; 2017; 2017():8124501. PubMed ID: 28421199 [TBL] [Abstract][Full Text] [Related]
30. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease. Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948 [TBL] [Abstract][Full Text] [Related]
31. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model. Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099 [TBL] [Abstract][Full Text] [Related]
32. Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity. Fang W; Gao G; Zhao H; Xia Y; Guo X; Li N; Li Y; Yang Y; Chen L; Wang Q; Li L Brain Res; 2015 Mar; 1602():9-19. PubMed ID: 25150591 [TBL] [Abstract][Full Text] [Related]
33. GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis. Lin CF; Chen CL; Chiang CW; Jan MS; Huang WC; Lin YS J Cell Sci; 2007 Aug; 120(Pt 16):2935-43. PubMed ID: 17666435 [TBL] [Abstract][Full Text] [Related]
34. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models. Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793 [TBL] [Abstract][Full Text] [Related]
35. Anti-Inflammatory Effect of IKK-Activated GSK-3β Inhibitory Peptide Prevented Nigrostriatal Neurodegeneration in the Rodent Model of Parkinson's Disease. Lee S; Hong DG; Yang S; Kim J; Baek M; Kim S; Thirumalai D; Chung HY; Chang SC; Lee J Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055183 [TBL] [Abstract][Full Text] [Related]
36. GSK-3 mediates nuclear translocation of p62/SQSTM1 in MPTP-induced mouse model of Parkinson's disease. Liu Y; Huang Q; Wei Z; Ma S; Woodgett JR; Li M; Li J Neurosci Lett; 2021 Oct; 763():136177. PubMed ID: 34400288 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue. Turkistani A; Al-Kuraishy HM; Al-Gareeb AI; Albuhadily AK; Alexiou A; Papadakis M; Elfiky MM; Saad HM; Batiha GE Mol Neurobiol; 2024 Sep; 61(9):7092-7108. PubMed ID: 38367137 [TBL] [Abstract][Full Text] [Related]
38. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease. Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210 [TBL] [Abstract][Full Text] [Related]
39. Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta. Sun X; Huang L; Zhang M; Sun S; Wu Y Toxicology; 2010 Apr; 271(1-2):5-12. PubMed ID: 20064577 [TBL] [Abstract][Full Text] [Related]